Research continues to grow as a source of hope and strength at the Indiana Biosciences Research Institute (IBRI).
In 2022, the IBRI increased its federal grant and sponsored research submissions by 52 percent leading to a total external funding growth increase of 9 percent.
As of December 31, 2022, IBRI investigators had more than three times the amount of funding opportunities planned and submitted compared to the prior year. This continued focus on diversified research funding will fuel future growth for the IBRI, ultimately benefiting the patients and community it serves.